glp-1 drugs mechanism of action Mechanisms Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy Regulation GLP-1 Agonists - What is
Description
GLP-1 agonists may be preferable in some elderly patients due to lower hypoglycemia risk, though GI side effects and potential for weight loss (which can be undesirable in frail elderly patients) require careful consideration
Is GLP-1 the Same as Ozempic for Medical Weight Loss
Approval for treatment is not guaranteed
In December 2024, Eli Lilly, the US pharmaceutical giant, announced the launch of its blockbuster drug, Tirzepatide, in India in 2025
The earliest possible commercial availability is likely late next year, though timelines may shift
